Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Leony Antoun"'
Autor:
Anthony Tarabay, Alice Boileve, Cristina Smolenschi, Leony Antoun, Marine Valery, Alina Fuerea, Audrey Perret, Pascal Burtin, Simona Cosconea, Hichem Belkhodja, David Malka, Valérie Boige, Antoine Hollebecque, Michel Ducreux
Publikováno v:
Biomedicines, Vol 11, Iss 9, p 2569 (2023)
Background: Pancreatic ductal adenocarcinoma (PDAC) is the third leading cause of death by cancer worldwide. Mostly diagnosed with locally advanced or metastatic disease, patients lack treatment options. Gene alterations (GAs) are frequently observed
Externí odkaz:
https://doaj.org/article/26a3fb018c8542f2bb1c09dce554c516
Autor:
Elsie Touma, Leony Antoun, Souheil Hallit, Fadi Nasr, Marcel Massoud, Radwan El Othman, Georges Chahine
Publikováno v:
BMC Public Health, Vol 21, Iss 1, Pp 1-8 (2021)
Abstract Background Lymphomas are ranked as the fifth most common cancer in Lebanon. There is concern about the need of information regarding the prevalence of lymphoid neoplasm particularly Non-Hodgkin lymphoma (NHL) subtypes in the Lebanese populat
Externí odkaz:
https://doaj.org/article/223ba2d95ff34c28b2b8e8c120efd5be
Autor:
Sabine Khalife-Hachem, Khalil Saleh, Florence Pasquier, Christophe Willekens, Anthony Tarabay, Leony Antoun, Thomas Grinda, Cristina Castilla-Llorente, Matthieu Duchmann, Cyril Quivoron, Nathalie Auger, Veronique Saada, Suzette Delaloge, Alexandra Leary, Aline Renneville, Ileana Antony-Debre, Filippo Rosselli, Stéphane De Botton, Flore Salviat, Christophe Marzac, Jean-Baptiste Micol
Publikováno v:
HemaSphere, Vol 5, Iss 9, p e632 (2021)
Definition of therapy-related myeloid neoplasms (TRMN) is only based on clinical history of exposure to leukemogenic therapy. No specific molecular classification combining therapy-related acute myeloid leukemia and therapy-related myelodysplastic sy
Externí odkaz:
https://doaj.org/article/49b74150c3484f2f99fdc14bfd50eb8c
Publikováno v:
PLoS ONE, Vol 13, Iss 1, p e0191541 (2018)
In non-dialysis chronic kidney disease patients, looking for iron deficiency is highly variable in practice and there is a great variability regarding the cutoffs used to treat iron deficiency. The aim of this study is to investigate the degree of ir
Externí odkaz:
https://doaj.org/article/4424974e03084f229c5af6f91275bb45
Publikováno v:
PLoS ONE, Vol 12, Iss 10, p e0185847 (2017)
There is so far no international consensus concerning the prescription of antithrombotic agents in hemodialysis patients. It is not clear yet why they cause more bleeding in some patients and are beneficial in others. We therefore tried to find out w
Externí odkaz:
https://doaj.org/article/842b8f32d77e44cbab1ce62353f0c101
Publikováno v:
Lebanese Medical Journal. 67:89-93
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::13da4576782533a91937993f7e64915a
https://doi.org/10.12816/0054122
https://doi.org/10.12816/0054122
Autor:
Leony Antoun, Marcel Massoud, Georges Chahine, Souheil Hallit, Elsie Touma, Fadi Nasr, Radwan El Othman
Publikováno v:
BMC Public Health
BMC Public Health, Vol 21, Iss 1, Pp 1-8 (2021)
BMC Public Health, Vol 21, Iss 1, Pp 1-8 (2021)
Background Lymphomas are ranked as the fifth most common cancer in Lebanon. There is concern about the need of information regarding the prevalence of lymphoid neoplasm particularly Non-Hodgkin lymphoma (NHL) subtypes in the Lebanese population. This
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2a92b9db32f83ff436b76535ba8edb0b
https://pubmed.ncbi.nlm.nih.gov/34627178
https://pubmed.ncbi.nlm.nih.gov/34627178
Publikováno v:
American journal of health behavior. 44(3)
Objectives: Hemodialysis is the most used renal replacement modality for end-stage renal disease patients. Dialysis patients are usually assessed for quality of life (QoL) but smiling was never studied. Duchenne smile is a genuine expression of joy,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2bc72b409ecaa2a70fc0cf0ec9a40314
https://pubmed.ncbi.nlm.nih.gov/32295679
https://pubmed.ncbi.nlm.nih.gov/32295679
Autor:
Anthony Tarabay, Antoine Hollebecque, Cristina Smolenschi, Leony Antoun, Caroline Klotz, Alina Fuerea, Audrey Perret, Claire Gouriou, Pascal Burtin, Hichem Belkhodja, Valérie Boige, David Malka, Michel Ducreux
Publikováno v:
Journal of Clinical Oncology. 40:605-605
605 Background: Pancreatic ductal adenocarcinoma (PDAC) is the third leading cause of death by cancer worldwide. Mostly diagnosed with locally advanced or metastatic disease, patients lack for treatment options. Gene alterations (GAs) are frequently
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::66bb3f2f6b47042b1e4a4f2a6c84d291
https://doi.org/10.1200/jco.2022.40.4_suppl.605
https://doi.org/10.1200/jco.2022.40.4_suppl.605
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 20:S264-S265
Context: Patients diagnosed with Non-Hodgkin Lymphoma (NHL) have been the subject of many epidemiologic studies done at the time that aimed to explain the distribution of different subtypes among different countries. Because there is unpublished data
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7bee9484728eb9b1eb1c5b923050180f
https://doi.org/10.1016/s2152-2650(20)30872-7
https://doi.org/10.1016/s2152-2650(20)30872-7